September 2019 FDA Recall Drug by West-ward Columbus Inc
D-1863-2019 - Failed Impurities/Degradation Specificattion
This Class II drug recall was voluntarily initiated by West-ward Columbus Inc on September 9, 2019 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specificattion. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-1863-2019
Failed Impurities/Degradation Specificattion
09-09-2019
09-25-2019
32,347 bottles
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
West-Ward Columbus Inc
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide USA and Puerto Rico
06-15-2022
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Oxcarbazepine Oral Suspension, USP, 300 mg/5 mL, 250 mL per bottle, Rx Only, Distr. by: West-Ward Pharmaceuticals,Eatontown, NJ. NDC:0054-0199-59
Batch or Lot Expiration Information
Lot# Lot, expiry: Lots AA3957A, AA3958A, exp May 2020; Lot AA5164A, exp Sep 2020